XTENT INC (XTNT) has 15 open-market insider trades by 12 insiders since 2007. The most active filer is Kent L. Swanson, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Orbimed ROF II LLC | 10% Owner | — | 1 | $61.4M | 2025-04-10 |
| Michael Eggenberg | Dir10% Owner | — | 1 | $13.6M | 2022-08-15 |
| Matthew Rizzo | Dir10% Owner | — | 1 | $13.6M | 2022-08-15 |
| Orbimed Advisors LLC | Dir10% Owner | — | 1 | $6.8M | 2022-08-15 |
| Stavros G. Vizirgianakis | Dir | — | 1 | $2.2M | 2026-08-15 |
| Robert C. Bellas Jr. | Dir | — | 1 | $400K | 2007-02-06 |
| Sean E. Browne | CEOPres | — | 1 | $54K | 2026-08-15 |
| Kevin D. Brandt | CCO | — | 1 | $50K | 2024-08-15 |
| Robert E. Flaherty | Dir | — | 1 | $32K | 2007-02-06 |
| Kent L. Swanson | Dir | — | 2 | $24K | 2017-07-25 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Orbimed ROF II LLC | 10% Owner | Sell | $61.4M | 2025-04-10 |
| Kevin D. Brandt | CCO | Buy | $50K | 2023-11-17 |
| Scott C. Neils | CFO | Sell | $5K | 2023-01-18 |
| Sean E. Browne | CEO & President | Sell | $140K | 2022-10-18 |
| Stavros G. Vizirgianakis | Director | Buy | $2.2M | 2022-10-07 |
| Scott C. Neils | CFO | Sell | $3K | 2022-08-16 |
Companies that share insiders with XTNT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Kevin D. Brandt | Chief Commercial Officer | Sell | $11K | 2022-08-16 |
| Orbimed Advisors LLC | Director & 10% | Buy | $6.8M | 2018-02-14 |
| Matthew Rizzo | Director & 10% Owner | Buy | $13.6M | 2018-02-14 |
| Daniel S. Goldberger | CEO | Buy | $12K | 2016-05-09 |
| Kent L. Swanson | Director | Buy | $9K | 2015-12-01 |
| David Louis Kirschman | EVP & Chief Scientific Officer & 10% | Buy | $6K | 2015-11-20 |
| Kent L. Swanson | Director | Buy | $15K | 2015-11-19 |
| David Louis Kirschman | EVP & Chief Scientific Officer & 10% | Buy | $6K | 2015-11-18 |
| Daniel S. Goldberger | CEO | Buy | $8K | 2015-11-16 |